Navigation Links
Questcor Reports Third Quarter 2010 Results
Date:10/28/2010

ANAHEIM, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the quarter ended September 30, 2010. Net sales totaled $31.3 million and net income was $11.5 million or $0.18 per diluted common share for the quarter ended September 30, 2010. The Company's financial performance was driven primarily by an increase in net sales for Acthar in the treatment of acute exacerbations of multiple sclerosis (MS). Acthar net sales for the treatment of infantile spasms (IS) continued to be within its historic range.

In the third quarter of 2009, the Company reported net income of $1.2 million or $0.02 per diluted common share on net sales of $13.9 million. Questcor's financial results in the third quarter of 2009 were negatively affected by the combination of a lower number of prescriptions for the treatment of IS, unusually high amounts of Medicaid rebates related to Acthar usage in previous quarters, and rebate reserves related to usage by the Tricare pharmacy network.

In the second quarter of 2010, the Company reported net income of $9.3 million or $0.14 per diluted common share on net sales of $28.3 million.

"The third quarter of 2010 results reflect the continued execution of our straightforward growth strategy for Acthar," said Don M. Bailey, President and CEO of Questcor. "We continue to have success in educating neurologists about the benefits of Acthar for patients afflicted with acute exacerbations of MS who have medical issues with steroids, the first-line treatment for this condition.

"With the recent approval from the FDA to market Acthar for the treatment of infantile spasms, we have initiated our commercial efforts in this therapeutic area," continued Mr. Bailey. "Importantly, the approval of Acthar as a treatment for IS also resulted in an updated and modernized label that allows fo
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Questcor Reports Solid Fourth Quarter Results
2. Questcor to Discuss Results From FDA Panel Meeting
3. Trading Halted Today in Questcor Pharmaceuticals Common Stock
4. Questcor to Present at the Jefferies 2010 Global Life Sciences Conference
5. Questcor Receives Notification of PDUFA Date Extension to September 11, 2010
6. Mitchell J. Blutt, M.D. Appointed to Questcor Board of Directors
7. Questcor to Present at UBS Global Life Sciences Conference
8. Questcor and Child Neurology Foundation Support the 2nd Annual Infantile Spasms (IS) Awareness Week
9. Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
10. Questcor to Present at the 21st Annual Oppenheimer Healthcare Conference
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , June 24, 2015 ... the addition of the "2015 Strategies in ... offering. This new 175-page report provides ... including diabetes (strips and meters), pregnancy, ovulation, and ... growth, regulatory requirements, technologies, and competitive profiles. ...
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:2015 Strategies in the Home/Self Testing Market 2OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... Technologies, Inc. (NYSE Amex: PTN ) today announced ... Palatin,s request to begin a Phase 2A proof-of-concept human trial ... administered formulation of PL-3994, an NPR-A agonist compound, in development ... "We are excited about the prospect of advancing PL-3994 into ...
... 3, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... preventive vaccines against cancers and infectious diseases, announced today that ... company overview at the ROTH 23rd Annual Growth Stock Conference ... A live and archived webcast will be accessible ...
Cached Medicine Technology:FDA Clears Palatin Technologies' IND Filing to Commence Clinical Studies for Asthma 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 2Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference 3
(Date:7/1/2015)... , ... July 01, 2015 , ... Incentivizing the use ... under control, with discounts as much as 80% or 90% off the prices for ... insurers need to act to mitigate the financial impact of these high-cost generic drugs. ...
(Date:7/1/2015)... ... ... The Recovery Workforce Summit: 2015 PRA Annual Conference , presented by ... as a keynote on June 2nd in Philadelphia, PA. Stossel led a timely keynote ... power and reach to the essential message, while opening doors to wellness and recovery. ...
(Date:7/1/2015)... ... July 01, 2015 , ... The executive ... and marketing of a number of nutritional and beauty products, announced the company ... ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This specific ECRM ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers protection ... to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor and ... Thule owners have come to expect. , The Thule Atmos X4 has ...
(Date:7/1/2015)... ... 01, 2015 , ... AvePoint, the established leader ... a new operational office in Zurich, Switzerland. The new facility will deliver enterprise-level ... business for organizations throughout the Swiss market. , “AvePoint is committed to ...
Breaking Medicine News(10 mins):Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 2Health News:Blues Execs Share Strategies for Managing Generic Drug Inflation in AIS Newsletter 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3
... By Alan Mozes HealthDay Reporter , ... every four U.S. health-care workers use some form of ... healthy, a new report shows. What,s more, doctors, ... were actually more likely than the general ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... Steve Jobs, tenure as CEO of Apple Inc. was the ... from the iPod to the iPhone to the iPad -- ... he was stepping down as the head of the hugely ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, Aug. ... most dreaded afflictions of old age, but the announcement by ... at age 59 has put a spotlight on the less ... , , About 500,000 people in the United States, or ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Aug. ... face higher odds of dying if they,re admitted over ... study finds equally good results for patients treated at ... the so-called "weekend effect" -- an increased risk of ...
... clinic isn,t enough to keep some trauma patients who have ... department (ED) for follow-up care, even for such minor needs ... Johns Hopkins research. Reporting in the Annals of ... Medicare and those with no insurance were 60 percent more ...
... , THURSDAY, Aug. 25 (HealthDay News) -- In ... a tornado, earthquake or fire, most dialysis patients don,t have ... to a new study. Although these kidney-disease patients rely ... University of North Carolina School of Medicine found that many ...
Cached Medicine News:Health News:Many Health-Care Workers Have Turned to Alternative Medicine 2Health News:Many Health-Care Workers Have Turned to Alternative Medicine 3Health News:Steve Jobs Faces Uphill Battle Against Cancer: Experts 2Health News:Steve Jobs Faces Uphill Battle Against Cancer: Experts 3Health News:Coach Summitt's Diagnosis Puts Spotlight on Early-Onset Alzheimer's 2Health News:Coach Summitt's Diagnosis Puts Spotlight on Early-Onset Alzheimer's 3Health News:Coach Summitt's Diagnosis Puts Spotlight on Early-Onset Alzheimer's 4Health News:Specialized Stroke Centers Deliver on the Weekends 2Health News:Specialized Stroke Centers Deliver on the Weekends 3Health News:Uninsured trauma patients are more likely to use the ED for follow-up care 2Health News:Uninsured trauma patients are more likely to use the ED for follow-up care 3Health News:Dialysis Patients Unprepared for Disasters, Study Contends 2
Naugle exophthalmometer is superior and inferior orbital rim-based instrument....
... easy-to-fit, daily disposable, spherical ... cast-mold technology, and designed ... correction of myopia and ... disposable contact lenses are ...
Both corneal topography and refractive error data are measured together in a single step to minimize alignment errors. Objective autorefractometry and autokeratometric readings of sphere, cylinder an...
... The only corneal topographer available ... optional built-in Pupillometer.,The German-engineered Keratograph delivers ... equally well for refractive surgery or ... exclusive optional infrared Pupillometer allows the ...
Medicine Products: